✦ LIBER ✦

A multi-center randomized trial to determine the safety and tolerability of combination treatment with ribavirin and infergen for HCV in naive patients

✍ Scribed by Paul J. Pockros

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

15 Open, multicenter, randomized, contro

✍ A. Craxi; G. Ideo; L. Demelia; A. Picciotto; A. Alberti; M. Pitaro; M. Rizzetto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

2009 SAFETY AND ANTIVIRAL ACTIVITY OF AN

✍ Lawitz, E.; Rodriquez-Torres, M.; Rustgi, V.K.; Hassanein, T.; Rahimy, M.H.; Cro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

O111 SAFETY AND EFFICACY OF TREATMENT WI

✍ Everson, G.T.; Tran, T.T.; Towner, W.J.; Davis, M.N.; Wyles, D.; Nahass, R.; McN 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 87 KB

5 PHASE 3 RANDOMIZED CONTROLLED TRIAL OF

✍ Gane, E.; Lawitz, E.; Rodriguez-Torres, M.; Gordon, S.; Dvory-Sobol, H.; Arterbu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN

✍ Jacobson, I.; Pockros, P.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONS

✍ M.S. Sulkowski; E. Ceasu; T. Asselah; F.A. Caruntu; J. Lalezari; P. Ferenci; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB